Michael Eckrich, MD

“There is no more important work than to help advance and pioneer transplant and cellular therapies to our patients who are in need. A good day is delivering acute, detail-oriented care to pediatric patients in need of blood cancer therapies.”

Dr. Eckrich is board certified in general pediatrics and pediatric hematology-oncology (cancer and blood disorders). He has special interests in curative bone marrow and stem cell transplantation therapies, immunotherapies and gene editing for sickle cell disease. He serves as medical director of Pediatric Transplant and Cellular Therapy at Atrium Health Levine Children’s Hospital.

He received his medical degree and completed a residency at the State University of New York. Dr. Eckrich also received a master’s degree in public health and completed fellowships at Vanderbilt University and the Center for International Blood and Marrow Transplant (CIBMTR) at the Medical College of Wisconsin.

Dr. Eckrich is involved in clinical research in novel transplant-related therapies and is a site-principal investigator for CRISPR gene editing for sickle cell disease. Prior to returning his transplant practice to Charlotte, he had successfully built a novel gene therapy program for sickle cell disease in San Antonio. Dr. Eckrich received an American Society of Clinical Oncology Young Investigator Award and a National Institutes of Health grant.

Outside of work, he loves spending time with his wife, son and daughter. They enjoy riding and climbing hills on road bicycles.